{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:29:03Z","timestamp":1792945743826,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing evidences supported that subjective cognitive decline (SCD) might be a potential first symptomatic manifestation of Alzheimer\u2019s disease (AD). The rapidly growing number of SCD individuals who seek medical help and advice also makes it urgent to develop more precise strategy for SCD. Therefore, this study aimed to explore the risk factors for SCD. Logistics and linear regression models were performed to investigate 41 factors for SCD in 1165 participants without objective cognitive impairment. Cochran-Armitage trend test was used to confirm the constant trend toward higher prevalence of SCD with an increasing number of risk factors. A high overall prevalence of SCD was found in total participants (42%). Eight factors were eventually identified as risk factors for SCD, including four stable factors associated with both SCD statues and severity (older age, thyroid diseases, minimal anxiety symptoms, and day time dysfunction; odds ratio (OR) ranging from 1.74 to 2.29) as well as four suggestive factors associated with either SCD statues or severity (female sex, anemia, lack of physical exercises, and living alone; OR ranging from 1.30 to 2.29). The prevalence of SCD gradually increased with the number of risk factors clustering increased in individuals (<jats:italic>p<\/jats:italic> for trend &lt;0.001). Five of these eight factors were further proved among individuals with SCD-plus features. These findings revealed several risk factors for SCD, providing some new clues for formulating priority strategies for early prevention of SCD.<\/jats:p>","DOI":"10.1038\/s41398-021-01711-1","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T19:05:38Z","timestamp":1636484738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Risk factors for subjective cognitive decline: the CABLE study"],"prefix":"10.1038","volume":"11","author":[{"given":"Chen","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Lin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-383X","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer\u2019s disease. Lancet. 2016;388:505\u201317.","journal-title":"Lancet"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med. 2018;378:321\u201330.","journal-title":"N Engl J Med"},{"key":"1711_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370:311\u201321.","journal-title":"N Engl J Med"},{"key":"1711_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:844\u201352.","journal-title":"Alzheimers Dement"},{"key":"1711_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/acps.12336","volume":"130","author":"AJ Mitchell","year":"2014","unstructured":"Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439\u201351.","journal-title":"Acta Psychiatr Scand"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jalz.2015.12.013","volume":"12","author":"RF Buckley","year":"2016","unstructured":"Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, et al. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:796\u2013804.","journal-title":"Alzheimers Dement"},{"key":"1711_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","volume":"8","author":"PJ Visser","year":"2009","unstructured":"Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, et al. Prevalence and prognostic value of CSF markers of Alzheimer\u2019s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009;8:619\u201327.","journal-title":"Lancet Neurol"},{"key":"1711_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13195-018-0444-1","volume":"10","author":"I de Rojas","year":"2018","unstructured":"de Rojas I, Romero J, Rodr\u00edguez-Gomez O, Pesini P, Sanabria A, P\u00e9rez-Cordon A, et al. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundacio ACE Healthy Brain Initiative (FACEHBI). Alzheimers Res Ther. 2018;10:119.","journal-title":"Alzheimers Res Ther"},{"key":"1711_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jamaneurol.2017.2216","volume":"74","author":"RF Buckley","year":"2017","unstructured":"Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, et al. Region-specific association of subjective cognitive decline with tauopathy independent of global beta-amyloid burden. JAMA Neurol. 2017;74:1455\u201363.","journal-title":"JAMA Neurol"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"e00776","DOI":"10.1002\/brb3.776","volume":"7","author":"CF Eliassen","year":"2017","unstructured":"Eliassen CF, Reinvang I, Selnes P, Grambaite R, Fladby T, Hessen E. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline. Brain Behav. 2017;7:e00776.","journal-title":"Brain Behav"},{"key":"1711_CR11","first-page":"1299","volume":"86","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2015;86:1299\u2013306.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1711_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","volume":"91","author":"JT Yu","year":"2020","unstructured":"Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91:1201\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1711_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/alz.12117","volume":"16","author":"W Xu","year":"2020","unstructured":"Xu W, Tan L, Su BJ, Yu H, Bi YL, Yue XF, et al. Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: the CABLE study. Alzheimers Dement. 2020;16:1146\u201352.","journal-title":"Alzheimers Dement"},{"key":"1711_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement"},{"key":"1711_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","volume":"13","author":"JL Molinuevo","year":"2017","unstructured":"Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13:296\u2013311.","journal-title":"Alzheimers Dement"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.dadm.2015.09.004","volume":"1","author":"KA Gifford","year":"2015","unstructured":"Gifford KA, Liu D, Romano R, Jones RN, Jefferson AL. Development of a subjective cognitive decline questionnaire using item response theory: a pilot study. Alzheimers Dement (Amst). 2015;1:429\u201339.","journal-title":"Alzheimers Dement (Amst)"},{"key":"1711_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S0033291796003923","volume":"27","author":"AF Jorm","year":"1997","unstructured":"Jorm AF, Christensen H, Korten AE, Henderson AS, Jacomb PA, Mackinnon A. Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med. 1997;27:91\u20138.","journal-title":"Psychol Med"},{"key":"1711_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271\u20138.","journal-title":"Lancet Neurol"},{"key":"1711_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopsych.2020.07.004","volume":"89","author":"W Xu","year":"2021","unstructured":"Xu W, Feng W, Shen XN, Bi YL, Ma YH, Li JQ, et al. Amyloid pathologies modulate the associations of minimal depressive symptoms with cognitive impairments in older adults without dementia. Biol Psychiatry. 2021;89:766\u201375.","journal-title":"Biol Psychiatry"},{"key":"1711_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"F Jessen","year":"2010","unstructured":"Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, K\u00f6lsch H, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67:414\u201322.","journal-title":"Arch Gen Psychiatry"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1212\/WNL.0000000000005863","volume":"91","author":"AC van Harten","year":"2018","unstructured":"van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, et al. Subjective cognitive decline and risk of MCI: the Mayo Clinic Study of Aging. Neurology. 2018;91:e300\u2013e312.","journal-title":"Neurology"},{"key":"1711_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0556-z","volume":"10","author":"LM Winchester","year":"2018","unstructured":"Winchester LM, Powell J, Lovestone S, Nevado-Holgado AJ. Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer\u2019s disease. Genome Med. 2018;10:51.","journal-title":"Genome Med"},{"key":"1711_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13195-018-0440-5","volume":"10","author":"B Tan","year":"2018","unstructured":"Tan B, Venketasubramanian N, Vrooman H, Cheng CY, Wong TY, Chen C, et al. Haemoglobin, magnetic resonance imaging markers and cognition: a subsample of population-based study. Alzheimers Res Ther. 2018;10:114.","journal-title":"Alzheimers Res Ther"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"e917","DOI":"10.1212\/WNL.0000000000008003","volume":"93","author":"FJ Wolters","year":"2019","unstructured":"Wolters FJ, Zonneveld HI, Licher S, Cremers L, Heart Brain Connection Collaborative Research Group, Ikram MK, et al. Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI. Neurology. 2019;93:e917\u2013e926. p","journal-title":"Neurology"},{"key":"1711_CR26","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1210\/jc.2015-2046","volume":"100","author":"G Pasqualetti","year":"2015","unstructured":"Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:4240\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1711_CR27","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/WNL.0000000000003227","volume":"87","author":"L Chaker","year":"2016","unstructured":"Chaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, et al. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology. 2016;87:1688\u201395.","journal-title":"Neurology"},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S0033291708003681","volume":"39","author":"M Hamer","year":"2009","unstructured":"Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med. 2009;39:3\u201311.","journal-title":"Psychol Med"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/gerona\/glaa268","volume":"76","author":"T Yoneda","year":"2021","unstructured":"Yoneda T, Lewis NA, Knight JE, Rush J, Vendittelli R, Kleineidam L, et al. The importance of engaging in physical activity in older adulthood for transitions between cognitive status categories and death: a coordinated analysis of fourteen longitudinal studies. J Gerontol A Biol Sci Med Sci. 2021;76:1661\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.arr.2020.101122","volume":"62","author":"R Desai","year":"2020","unstructured":"Desai R, John A, Stott J, Charlesworth G. Living alone and risk of dementia: a systematic review and meta-analysis. Ageing Res Rev. 2020;62:101122.","journal-title":"Ageing Res Rev"},{"key":"1711_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2015.04.006","volume":"22","author":"JS Kuiper","year":"2015","unstructured":"Kuiper JS, Zuidersma M, Oude Voshaar RC, Zuidema SU, van den Heuvel ER, Stolk RP, et al. Social relationships and risk of dementia: a systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev. 2015;22:39\u201357.","journal-title":"Ageing Res Rev"},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.12966","volume":"139","author":"J Santab\u00e1rbara","year":"2019","unstructured":"Santab\u00e1rbara J, Lopez-Anton R, de la C\u00e1mara C, Lobo E, Gracia-Garc\u00eda P, Villagrasa B, et al. Clinically significant anxiety as a risk factor for dementia in the elderly community. Acta Psychiatr Scand. 2019;139:6\u201314.","journal-title":"Acta Psychiatr Scand"},{"key":"1711_CR33","unstructured":"Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, et al. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Mol Psychiatry. 2020."},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13195-020-00673-8","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alzheimers Res Ther. 2020;12:107.","journal-title":"Alzheimers Res Ther"},{"key":"1711_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-019-0505-0","volume":"11","author":"Y Sun","year":"2019","unstructured":"Sun Y, Wang X, Wang Y, Dong H, Lu J, Scheininger T, et al. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE epsilon4 carriers versus APOE epsilon4 non-carriers. Alzheimers Res Ther. 2019;11:50.","journal-title":"Alzheimers Res Ther"},{"key":"1711_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/jnnp-2019-321896","volume":"91","author":"W Xu","year":"2020","unstructured":"Xu W, Tan CC, Zou JJ, Cao XP, Tan L. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91:236\u201344.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40520-018-1005-y","volume":"31","author":"Y Liang","year":"2019","unstructured":"Liang Y, Qu LB, Liu H. Non-linear associations between sleep duration and the risks of mild cognitive impairment\/dementia and cognitive decline: a dose\u2013response meta-analysis of observational studies. Aging Clin Exp Res. 2019;31:309\u201320.","journal-title":"Aging Clin Exp Res"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01711-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01711-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01711-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:34:46Z","timestamp":1669908886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01711-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01711-1","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}